Efficacy Study of Metadoxine SR Formulation in Attention Deficit Hyperactivity Disorder (ADHD) Subjects
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
This clinical study is designed to evaluate the safety and tolerability of a single oral
administration of a Metadoxine slow release formulation to subjects diagnosed as having ADHD.
Study also assess cognitive effects of such drug administration.